View Single Post
Old 03-13-2010, 09:18 AM   #9
1rarebird
Senior Member
 
Join Date: Feb 2010
Location: TN
Posts: 175
Re: Risk of Recurrent Disease in HER2-Positive Patients

This GUN study is a real eye-opener for me. I will have to take it up with my doctor soon. One thing I believe I am seeing in figure 5. of the report is that for at least the first year to year and a half there does not appear to be any significance in the OS of the Her2+/ER+ with TAM group versus those not taking TAM. Hopefully, that should allow me enough time to work out the pros and cons of switching to an AI or finding a way to continue the Her2 blockade once my Herceptin year ends in July.

This hormonal therapy is so complicated. Out of all the therapies I have had to deal with since diagnosis last year, it has been the hardest by far for me to deal with.

bird
__________________
Male Breast Cancer, DX 5/15/09, IDC, STAGE 1, 1.7 cm, HER2+++, ER+(95%)/PR+(75%), Ki67 40%, grade 3, 0/5 nodes, TX: mastectomy, TCH finished 7/19/10, radiation 6 wks., Tamoxifen on going, bisphosphonate 24 mos.
1rarebird is offline   Reply With Quote